Ranibizumab Effective for Wet Macular DegenerationRanibizumab Effective for Wet Macular Degeneration
Two-year results from the HARBOR trial are in, and they show an individualized treatment approach with ranibizumab is appropriate for treatment-naive patients with age-related macular degeneration. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Health | Lucentis | Opthalmology | Ranibizumab Injection